Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days

Effendy, Isaak; Gelber, A.; Lehmann, P.; Huledal, G.; Lillieborg, S.

Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days

Effendy I, Gelber A, Lehmann P, Huledal G, Lillieborg S (2015)
British Journal of Dermatology 173(1): 259-261.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

bjd0259.pdf 129.72 KB

URL

https://academic.oup.com/bjd/article/173/1/259/6616501

DOI

https://doi.org/10.1111/bjd.13605

URN

urn:nbn:de:0070-pub-29696431

Autor*in

Effendy, Isaak^UniBi ; Gelber, A.; Lehmann, P.; Huledal, G.; Lillieborg, S.

Einrichtung

Medizinische Fakultät OWL > Vertretungsprofessur für Dermatologie

Erscheinungsjahr

2015

Zeitschriftentitel

British Journal of Dermatology

Band

173

Ausgabe

1

Seite(n)

259-261

Urheberrecht / Lizenzen

Creative Commons Namensnennung-Nicht kommerziell 4.0 International (CC BY-NC 4.0)

ISSN

0007-0963

eISSN

1365-2133

Page URI

https://pub.uni-bielefeld.de/record/2969643

Zitieren

Effendy I, Gelber A, Lehmann P, Huledal G, Lillieborg S. Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days. British Journal of Dermatology. 2015;173(1):259-261.

Effendy, I., Gelber, A., Lehmann, P., Huledal, G., & Lillieborg, S. (2015). Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days. British Journal of Dermatology, 173(1), 259-261. https://doi.org/10.1111/bjd.13605

Effendy, Isaak, Gelber, A., Lehmann, P., Huledal, G., and Lillieborg, S. 2015. “Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days”. British Journal of Dermatology 173 (1): 259-261.

Effendy, I., Gelber, A., Lehmann, P., Huledal, G., and Lillieborg, S. (2015). Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days. British Journal of Dermatology 173, 259-261.

Effendy, I., et al., 2015. Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days. British Journal of Dermatology, 173(1), p 259-261.

I. Effendy, et al., “Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days”, British Journal of Dermatology, vol. 173, 2015, pp. 259-261.

Effendy, I., Gelber, A., Lehmann, P., Huledal, G., Lillieborg, S.: Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days. British Journal of Dermatology. 173, 259-261 (2015).

Effendy, Isaak, Gelber, A., Lehmann, P., Huledal, G., and Lillieborg, S. “Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer‐related pain during daily application of lidocaine–prilocaine cream (EMLA (TM)) for 10 days”. British Journal of Dermatology 173.1 (2015): 259-261.

Alle Dateien verfügbar unter der/den folgenden Lizenz(en):

Creative Commons Namensnennung-Nicht kommerziell 4.0 International (CC BY-NC 4.0):